Proteomic analyses in diverse populations improved risk prediction and identified new drug targets for type 2 diabetes - Yao, P; Iona, A; Pozarickij, A; Said, S; Wright, N; Lin, K; Millwood, I; Fry, H; Kartsonaki, C; Mazidi, M; Chen, Y; Bragg, F; et al. (Diabetes Care, 2024)